(36) longitudinally examined tumor hemodynamics in two types of breast cancer xenografts focusing particularly on HbT and StO2 changes with the administration of bevacizumab, a drug that targets circulating VEGF and prevents it from attaching to its cell membrane receptors. The gene discussed is VEGFA; the disease is neoplasm.